be? Is a women who was diagnosed 7 years ago by her GP still eligible for the study? 2. Intervention: How is heart rate being calculated and assessed during exercise sessions, both under supervision and unsupervised? Is it based on baseline Vo2max testing, or estimated via equation? Will the training HR zone be adjusted with improvements in VO2 in the latter weeks of training? What devices (if any) will be used to assess HR? Introduction 1. What is the rationale related to the comparison between two HIIT protocols, specifically a high-volume vs. low-volume HIIT? Please, clarify this aspect, especially linking the comparison of the HIIT protocols with the main outcome; i.e. reproductive function or, actually, its proxy -menstruation frequency. 2. Regarding the structure of the HIIT interventions, semisupervised and home-based, please justify this methodological approach and its implications for the outcomes, especially the main outcome. 3. Could the authors justify the use of 'menstrual frequency' as a proxy of 'ovulation' and, as a consequence, reproductive function? Indeed, PCOS women do not have a regular menstrual frequency and ovulatory cycle. However, even a PCOS women with a regular menstrual frequency not necessarily ovulate. Therefore, the use of 'menstrual frequency' as a proxy of 'ovulation' and reproductive function has limitations. Please, clarify these points raised and consider to include the limitations of the use of 'menstrual frequency' as a proxy of 'ovulation' and reproductive function. Methods 1. For the clinical identification of hyperandrogenism, is the cutoff for Ferriman-Gallwey Score > 6 or > 8, according to Rotterdam criteria? 2. Regarding the inclusion criterion of 'untrained status', it seems allow the inclusion of a physically active women. For example, if a PCOS women is involved in a regular resistance training program 4 times per week, she can be included in the intervention according to the adopted criteria, but in this case she is a trained person. Could the authors clarify this point? 3. In the exclusion criteria it is stated that 'endocrine disorders' will be considered as an exclusion criterion. Is type II diabetes included in the list of 'endocrine disorders'. This is important clarify because type II diabetes is highly prevalent in PCOS women. 4. Randomization and allocation: Could the authors explain the reasons to stratify and randomize the participants based on BMI < and > 27 kg/m2? 5. Interventions: I have important concerns about the terms used to describe the interventions and also how it will be conducted. I some parts the definitions seem contradictory. In the introduction section, the authors stated that "The primary aim of the IMPROV-IT trial is to test the hypothesis that 16 weeks of semi-supervised HIT, followed by home-based HIT for 36 weeks…". However, in the methods section, the authors describe the intervention as "The first 16 weeks of the exercise training will be partly or fully supervised, with the remaining 36 weeks of the intervention organized as home-based exercise training". First, in my understanding a semi-supervised exercise training intervention is a mixed of supervised and unsupervised exercise training sessions. This is not the case for the first 16 weeks of intervention. Indeed, there are two different possibilities for the participants: 1) a whole supervised exercise training intervention or 2) a semi-supervised exercise training intervention, based on their choices. This seems to be a considerable source of bias that can impact the primary and secondary outcomes. For example, it is possible that some participants choose to perform few or a lot of exercise training sessions at home while the other participants complete all exercise training sessions at a supervised setting. Given that HIIT requires a higher level of effort and motivation, at an unsupervised setting the participants could not reach the prescribed intensity and/or the number of the high-intensity work bouts. Please, clarify. Second, in my understanding a home-based intervention is when the an exercise training intervention is delivered for and performed at an unsupervised setting. According to authors' definition of homebased exercise training is not clear if the participants will have the opportunity to perform some exercise training sessions at a supervised setting or not. Please, clarify. 6. Regarding the control group, it is not clear how the physical activity advice will be conducted. Is it at an individual face-to-face meeting? It is not clear if they will stimulated to perform MICT or if they will received some printed orientations to perform structured or unstructured physical activity. Please, clarify. 7. The 4x4 HIIT protocols is well described and it follows the description of previous studies that have used this Scandinavian HIIT model. However, in the 10x1 HIIT protocol is not clear how the participants will be instructed to reach the training zone of the high-intensity work bouts. The authors defined the training zone as "…maximal intensity the participants can complete for one minute". This is a very open definition. As HR is not an adequate variable to prescribe low-volume HIIT, previous studies have used other parameters, such as an specific RPE target (e.g. 15-17 on Borg's 6-20 RPE scale) or % of the PPO reached at the maximal graded exercise test (e.g. 60% of PPO for cycle ergometers HIIT protocols or 90-100% of maximal treadmill velocity for HIIT protocols performed on treadmill). In addition, the type of recovery is not standardized for the low-volume HIIT protocol, which can interfere in the next high-intensity work bouts. For example, some women can adopt a passive recovery and have a better recovery and perform the next work bout at a higher intensity than a participant who adopted an active recovery. In summary, while the 4x4 HIIT is well described and detailed the 10x1 HIIT protocol is poor described. In addition, the authors could state that these protocols are not matched by time, mean workload, energy expenditure, etc. which informs to the readers that they are two very different exercise training approaches considering the HIIT possibilities. Maybe describe them as low-and high-volume HIIT protocols. 8. Regarding the outcomes, please in the end of the description of each outcome state if its assessment will be blinded or not when adequate (e.g. ovarian morphology; endothelial function; etc.). 9. The assessment of the primary outcome should be better described. It is not clear if the participants will complete the questionnaire every month or only at the specific time points (pre, post-16 weeks and 12 months). If the participants complete the questionnaires at the specific time points, it is not clear if they will inform about their menstrual frequency retrospectively or only at this specific month. Also, describe the questionnaire that the participants will answer. Is it a valid questionnaire? Is it specific for PCOS women? Please, clarify. 10. In the cardiorespiratory fitness assessments, please clarify which criteria will be used to define a maximal graded exercise test. In addition, the authors state that the HRmax obtained in the maximal graded exercise test will be used for HIIT prescription. This is not clear for the 10x1 HIIT protocol. Please, describe how the HRmax will be used to prescribe the low-volume HIIT. Or it will be used only for the HIIT intensity monitoring? 11. Regarding the monitoring of physical activity as a possible confounding variable, please describe which questionnaire will be used. 12. Regarding the body composition assessment two different methods will be used in the centers, which are bioelectrical impedance and DXA. These methods are very different and have different magnitudes of technical error of measurement and reliability. How the authors will analyzed the data related to body composition (i.e. which variables; separate data per center or all together; etc.)? Also, please states the implications of using two very different methods to assess body composition in the same study. 13. Regarding the enjoyment outcome, it is not clear how a subgroup of participants and how many will be chosen to answer the PACES questionnaire. It will be a random process? Please, describe this procedure. The enjoyment will be assessed at the supervised or unsupervised sessions or both? Please, clarify. If only in the supervised sessions it would be a considerable source of bias for this outcome given that at supervised setting the participants can have a verbal encouragement, support and motivation from the research staff. Also, they can have a social support from other participants. Together, these aspects can influence perceived enjoyment of an exercise training session. This should be better described especially because recent literature has showed conflicting findings regarding affective response (i.e. pleasure/displeasure) during and enjoyment after HIIT sessions in different populations. 14. Regarding the sample size calculation, the expected change from 4.5 for 7.5 menstrual bleedings per year in the exercise group is based on a previous study? Please, justify. Also, do the authors expect any difference from the HIIT groups? If yes, any statistical approach was used to allow comparisons between these groups with adequate power? 15. Blinding. It is a nice approach to run all the statistical analyses blinded for group allocation. However, the primary outcome assessment is not blinded. Why menstrual frequency assessment was not blinded? Discussion 1. The authors do not discuss the scientific and clinical implications of the comparisons between the effects of both HIIT protocols. Please, clarify. 2. The authors do not discuss the limitations of the trial design and outcomes analyzed, especially the primary outcome. Please, clarify.
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Please state any competing interests or state 'None declared': None Please leave your comments for the authors below bmjopen-2019-034733: Improving Reproductive Function in Women with Polycystic Ovary Syndrome with High-Intensity Interval Training (IMPROV-IT): study protocol for a two-centre, three-armed randomized controlled trial This is a well-written protocol for a novel RCT of high-intensity interval training (HIT) in women with PCOS. My concerns are relatively minor and may be considered and addressed by the authors if they feel it will improve the quality of their manuscript.
Introduction: 1. The rationale for investigating two HIT protocols was not articulated in the introduction. Please address. Response: We have now added the following paragraph to the introduction to clarify the rationale for choosing to investigate two HIT protocols: "Although moderate intensity exercise provides health benefits, vigorous, but not moderate intensity physical activity, was associated with reduced odds of insulin resistance and metabolic syndrome in a cross-sectional study of women with PCOS.18 Indeed, there has been an increased focus on high-intensity interval training (HIT) as a means of improving insulin sensitivity28 and cardiorespiratory fitness29-31 in clinical populations, including PCOS.32 HIT involves brief, repeated work-boats of relatively intense exercise separated by periods of rest or low-intensity exercise. Several different HIT protocols exist, and they can broadly be divided into "high-volume" and "low-volume" HIT. One of the most common high-volume (HV) HIT protocols is the Norwegian 4 x 4 min HIT protocol, which induces superior improvements in cardiorespiratory fitness than work-matched moderate intensity training in both healthy individuals33 and in various patient groups.29 34 Low-volume (LV) HIT typically consists of ≤ 10 min of intense exercise within an exercise session lasting ≤ 30 min in total, such that the total weekly training time commitment is markedly lower than the current public health guidelines.35 Low-volume HIT could therefore have the potential to overcome the most common barrier for women in fertile age, such as time-commitment.36 Low-volume HIT can improve glycaemic control in people with type 2 diabetes.37 We have previously reported improved insulin sensitivity (measured with homeostatic assessment of insulin resistance, HOMA-IR), endothelial function and body composition after ten weeks of HIT in women with PCOS, without any changes in body mass.32 However, in that pilot study the participants undertook both lowvolume and high-volume HIT and we did not determine the effects of exercise training on any reproductive outcomes. Based on the positive results from our pilot study with a combined high -and low volume HIT protocol, we will now compare the two different HIT protocols to investigate potential differences in health outcomes." 2. The rationale for partial supervision and participant choice/autonomy (i.e. aspects of behavior change) were not provided in the Introduction. Please address. Response: We have now tried to clarify the reason for choosing a partially supervised training program. In the methods section, we have added the following: "The first 16 weeks of the exercise training will be semi-supervised, with the remaining 36 weeks of the intervention organized as homebased exercise training without any supervision. Supervised exercise interventions are effective, but do not resemble a real-life setting, and the long-term adherence often falls once the supervised exercise program ends. Unsupervised exercise programs are more easily implemented and flexible, but adherence is often low. During the first 16 weeks, the participants will perform at least one weekly supervised exercise session at the study centres. They will be given the opportunity to attend up to three weekly supervised exercise sessions but can also choose to do one or two of the weekly sessions as home-based training."
We have also added the following to the discussion: "We chose to implement a semi-supervised exercise program to account for the individual preferences of the participants and to be able to include women living further away from the study centres. Such protocols can both control the exercise intervention and motivate participants, and at the same time give more flexibility based on participants' preferences." 3. I know it can be challenging, but the authors should attempt to provide a rationale for the collection of all outcomes measures. This was not done for some of the secondary outcomes (e.g. inflammation, oxidative metabolism, adipose tissue). A large section of the introduction was spent articulating 'lines of therapy' (paragraph 1), which can be referenced out, and there were several sentences about a study in women with normal/low BMI (Line 16-25), which is not critically important to review in detail given that it is not the same sub-sample being investigated in this study. Response: We have now removed some of the "lines of therapy" and added the following paragraph to the introduction: "Adipose tissue dysfunction, such as hypertrophic adipocytes and impairments in lipolysis and insulin action, plays a central role in the metabolic abnormalities observed in PCOS.15 Hypertrophic adipocytes are more susceptible to inflammation and chronic low-grade inflammation is reported in PCOS.16 There is limited research on the effect of exercise training on adipose tissue function in PCOS." 4. Line 39, "According to the most recent guidelines…" requires a reference. Response: We have added a reference here (Teede H et al, 2018) .
Method: 1. Participants: is there an eligibility restriction on the time since PCOS diagnosis? In other words, how recent should the diagnosis be? Is a women who was diagnosed 7 years ago by her GP still eligible for the study? Response: We have now added the following paragraph to the method section (under participants): "At the Norwegian centre, all participants will be screened at baseline for polycystic ovaries, hyperandrogenism and menstruation to confirm the PCOS diagnosis. At the Australian centre, participants will show an ultrasound scan no older than 8 years performed by their general practitioner, gynecologist or endocrinologist confirming polycystic ovaries. Ferriman Gallway score for hirsutism/hyperandrogenism and information about their menstrual cycle will be obtained before entering the study to confirm PCOS diagnosis." 2. Intervention: How is heart rate being calculated and assessed during exercise sessions, both under supervision and unsupervised? Is it based on baseline Vo2max testing, or estimated via equation? Will the training HR zone be adjusted with improvements in VO2 in the latter weeks of training? What devices (if any) will be used to assess HR? Response: We have now tried to clarify these questions in the method section (under intervention). We have added the following: "Heart rate monitors (Polar M400) will be used on all sessions, including on the home-based sessions, and the exercise intensity will be estimated based on their HRmax during the VO2max test at baseline.42"
Participants receive a written version of the exercise protocol as well as oral information about the intensity zones and are comfortable with the protocol before they perform home-based exercise. Since the HR zone is based on their HRmax (that is expected to be constant during the interventionand follow-up period), we will not adjust the HR zones. They are instructed to follow the HR zones that are stated in the exercise protocols, but we have specified in the manuscript that we will adjust the absolute workload of both HIT protocols throughout the intervention period to account for improvements in fitness.
Exercise sessions (both supervised and home-based) will be uploaded by the participants to an online exercise tool (Polar Flow). The researchers have access to all sessions via the same online tool (Polar Flow for Coach). To clarify this aspect, we have added the following: "The researchers will have access to all sessions via the same online tool and will supervise exercise adherence at the home-based sessions, however no motivational support or instructions will be provided during the follow-up period. Overall the manuscript is well-written and addresses an important research question which has clinical implications for its specific field. Moreover, the manuscript meets the SPIRIT. However, there are some points that should be more clear in the manuscript, especially in the introduction and methods. Please, see the specific comments.
Specific comments Abstract
It is not clear the rationale related to the specific investigation about the effect of HIIT, and not MICT or resistance training, for example, on reproductive function. I suggest that the author include this aspect. Also, the rationale related to the comparison between two HIIT protocols. As 'menstruation frequency' is not an objective marker of reproductive function, but only a proxy of, I suggest to include this aspect in the abstract to make it clear for the readers. Response: We have added this sentence to the abstract " Previous findings indicate superior metabolic health benefits after vigorous compared to moderate intensity exercise."
We have now included menstrual frequency as our primary aim is the abstract, as a proxy of reproductive function: "Our primary aim is to determine the effect of high-intensity interval training on menstrual frequency, as a proxy of reproductive function, in women with PCOS." Due to word limitation in the abstract, we have chosen to clarify the rationale for comparing two HIT protocols in the Introduction section (please see below). Introduction 1. What is the rationale related to the comparison between two HIIT protocols, specifically a highvolume vs. low-volume HIIT? Please, clarify this aspect, especially linking the comparison of the HIIT protocols with the main outcome; i.e. reproductive function or, actually, its proxy -menstruation frequency. Response: We have now added the following paragraph to the introduction to clarify the rationale for choosing to investigate two HIT protocols: "Although moderate intensity exercise provides health benefits, vigorous, but not moderate intensity physical activity, was associated with reduced odds of insulin resistance and metabolic syndrome in a cross-sectional study of women with PCOS.18 Indeed, there has been an increased focus on high-intensity interval training (HIT) as a means of improving insulin sensitivity28 and cardiorespiratory fitness29-31 in clinical populations, including PCOS.32 HIT involves brief, repeated work-boats of relatively intense exercise separated by periods of rest or low-intensity exercise. Several different HIT protocols exist, and they can broadly be divided into "high-volume" and "low-volume" HIT. One of the most common high-volume (HV) HIT protocols is the Norwegian 4 x 4 min HIT protocol, which induces superior improvements in cardiorespiratory fitness than work-matched moderate intensity training in both healthy individuals33 and in various patient groups.29 34 Low-volume (LV) HIT typically consists of ≤ 10 min of intense exercise within an exercise session lasting ≤ 30 min in total, such that the total weekly training time commitment is markedly lower than the current public health guidelines.35 Low-volume HIT could therefore have the potential to overcome the most common barrier for women in fertile age, such as time-commitment.36 Low-volume HIT can improve glycaemic control in people with type 2 diabetes.37 We have previously reported improved insulin sensitivity (measured with homeostatic assessment of insulin resistance, HOMA-IR), endothelial function and body composition after ten weeks of HIT in women with PCOS, without any changes in body mass.32 However, in that pilot study the participants undertook both lowvolume and high-volume HIT and we did not determine the effects of exercise training on any reproductive outcomes. Based on the positive results from our pilot study with a combined high -and low volume HIT protocol, we will now compare the two different HIT protocols to investigate potential differences in health outcomes." 2. Regarding the structure of the HIIT interventions, semi-supervised and home-based, please justify this methodological approach and its implications for the outcomes, especially the main outcome.
Response:
We have now tried to clarify the reason for choosing a partially supervised training program. In the methods section, we have added the following: "The first 16 weeks of the exercise training will be semi-supervised, with the remaining 36 weeks of the intervention organized as homebased exercise training without any supervision. Supervised exercise interventions are effective, but do not resemble a real-life setting, and the long-term adherence often falls once the supervised exercise program ends. Unsupervised exercise programs are more easily implemented and flexible, but adherence is often low. During the first 16 weeks, the participants will perform at least one weekly supervised exercise session at the study centres. They will be given the opportunity to attend up to three weekly supervised exercise sessions but can also choose to do one or two of the weekly sessions as home-based training."
We have also added the following to the discussion: "We chose to implement a semi-supervised exercise program to account for the individual preferences of the participants and to be able to include women living further away from the study centres. Such protocols can both control the exercise intervention and motivate participants, and at the same time give more flexibility based on participants' preferences."
3. Could the authors justify the use of 'menstrual frequency' as a proxy of 'ovulation' and, as a consequence, reproductive function? Indeed, PCOS women do not have a regular menstrual frequency and ovulatory cycle. However, even a PCOS women with a regular menstrual frequency not necessarily ovulate. Therefore, the use of 'menstrual frequency' as a proxy of 'ovulation' and reproductive function has limitations. Please, clarify these points raised and consider to include the limitations of the use of 'menstrual frequency' as a proxy of 'ovulation' and reproductive function.
Response: We agree that menstrual frequency is only a proxy of ovulation/reproductive function in PCOS, and that this outcome measure has its limitation. We will use our primary outcome, together with several secondary outcomes (ultrasound of ovaries, blood samples, OGGT, body composition and pregnancy rate) to discuss the effect of exercise training on reproductive function in women with PCOS. We have included the following in the limitation paragraph: "Our trial has some limitations. The use of menstrual frequency as a proxy for ovulation/reproductive function is one of these. Due to practical reasons, we are not able to undertake ovulation monitoring." Methods 1. For the clinical identification of hyperandrogenism, is the cutoff for Ferriman-Gallwey Score > 6 or > 8, according to Rotterdam criteria? Response: Thank you for making us aware of this typo. In the Nordic PCOS population, a Ferriman G. score >6 may be used according to the new guidelines. However, in this study we include women from both Norway and Australia, and therefore, we will use a score >8, as described in the 2003 Rotterdam criteria.
2. Regarding the inclusion criterion of 'untrained status', it seems allow the inclusion of a physically active women. For example, if a PCOS women is involved in a regular resistance training program 4 times per week, she can be included in the intervention according to the adopted criteria, but in this case she is a trained person. Could the authors clarify this point? Response: We understand that this was confusing and have rephrased this sentence: "Undertaking less than two weekly endurance exercise training sessions with an intensity that induce heavy breathing." Regular resistance training is not an exclusion criterion in our study. We will, however, record other types of exercise training in our questionnaire.
3. In the exclusion criteria it is stated that 'endocrine disorders' will be considered as an exclusion criterion. Is type II diabetes included in the list of 'endocrine disorders'. This is important clarify because type II diabetes is highly prevalent in PCOS women.
Response: Women who have type 2 diabetes will not be excluded. However, medical treatment with insulin-sensitizing agents such as Metformin is an exclusion criterion.
Randomization and allocation:
Could the authors explain the reasons to stratify and randomize the participants based on BMI < and > 27 kg/m2? Response: We chose to stratify on BMI above or below 27 to ensure that the proportion of women with insulin resistance would be similar in all groups. This is based on Stepto et al (Hum Reprod 2013) which reports a distinction in the prevalence of insulin resistance among lean versus obese groups based on a BMI threshold of 27 kg/m2. 5. Interventions: I have important concerns about the terms used to describe the interventions and also how it will be conducted. I some parts the definitions seem contradictory. In the introduction section, the authors stated that "The primary aim of the IMPROV-IT trial is to test the hypothesis that 16 weeks of semi-supervised HIT, followed by home-based HIT for 36 weeks…". However, in the methods section, the authors describe the intervention as "The first 16 weeks of the exercise training will be partly or fully supervised, with the remaining 36 weeks of the intervention organized as homebased exercise training". First, in my understanding a semi-supervised exercise training intervention is a mixed of supervised and unsupervised exercise training sessions. This is not the case for the first 16 weeks of intervention. Indeed, there are two different possibilities for the participants: 1) a whole supervised exercise training intervention or 2) a semi-supervised exercise training intervention, based on their choices. This seems to be a considerable source of bias that can impact the primary and secondary outcomes. For example, it is possible that some participants choose to perform few or a lot of exercise training sessions at home while the other participants complete all exercise training sessions at a supervised setting. Given that HIIT requires a higher level of effort and motivation, at an unsupervised setting the participants could not reach the prescribed intensity and/or the number of the high-intensity work bouts. Please, clarify. Second, in my understanding a home-based intervention is when the an exercise training intervention is delivered for and performed at an unsupervised setting. According to authors' definition of home-based exercise training is not clear if the participants will have the opportunity to perform some exercise training sessions at a supervised setting or not. Please, clarify. Response: We understand the confusion, and have tried to clarify the terms used to describe the intervention. The first 16 weeks will be semi-supervised with at least one supervised session per week. The remaining two sessions per week can be supervised or home-based, based on participant preferences. The remaining 36 weeks follow-up period consists of two home-based exercise sessions per week (unsupervised): ""The first 16 weeks of the exercise training will be semi-supervised, with the remaining 36 weeks of the intervention organized as home-based exercise training without any supervision. Supervised exercise interventions are effective, but do not resemble a real-life setting, and the long-term adherence often falls once the supervised exercise program ends. Unsupervised exercise programs are more easily implemented and flexible, but adherence is often low. During the first 16 weeks, the participants will perform at least one weekly supervised exercise session at the study centres. They will be given the opportunity to attend up to three weekly supervised exercise sessions but can also choose to do one or two of the weekly sessions as home-based training."
We have also added the following to the discussion: "We chose to implement a semi-supervised exercise program to account for the individual preferences of the participants and to be able to include women living further away from the study centres. Such protocols can both control the exercise intervention and motivate participants, and at the same time give more flexibility based on participants' preferences." 6. Regarding the control group, it is not clear how the physical activity advice will be conducted. Is it at an individual face-to-face meeting? It is not clear if they will stimulated to perform MICT or if they will received some printed orientations to perform structured or unstructured physical activity. Please, clarify. Response: Participants are informed about the current recommendations for physical activity in the information letter and orally after the randomization: "We will be advising women in the control group to continue their habitual physical activity and inform them about the current recommendations of a minimum of 150 minutes of weekly moderate intensity physical activity." 7. The 4x4 HIIT protocols is well described and it follows the description of previous studies that have used this Scandinavian HIIT model. However, in the 10x1 HIIT protocol is not clear how the participants will be instructed to reach the training zone of the high-intensity work bouts. The authors defined the training zone as "…maximal intensity the participants can complete for one minute". This is a very open definition. As HR is not an adequate variable to prescribe low-volume HIIT, previous studies have used other parameters, such as an specific RPE target (e.g. 15-17 on Borg's 6-20 RPE scale) or % of the PPO reached at the maximal graded exercise test (e.g. 60% of PPO for cycle ergometers HIIT protocols or 90-100% of maximal treadmill velocity for HIIT protocols performed on treadmill). In addition, the type of recovery is not standardized for the low-volume HIIT protocol, which can interfere in the next high-intensity work bouts. For example, some women can adopt a passive recovery and have a better recovery and perform the next work bout at a higher intensity than a participant who adopted an active recovery. In summary, while the 4x4 HIIT is well described and detailed the 10x1 HIIT protocol is poor described. In addition, the authors could state that these protocols are not matched by time, mean workload, energy expenditure, etc. which informs to the readers that they are two very different exercise training approaches considering the HIIT possibilities. Maybe describe them as low-and high-volume HIIT protocols. Response: We thank you for suggesting to describe the two protocols as low-and high-volume HIT.
We have now changed this throughout the manuscript and have added to the Methods section that the two protocols are not matched for time, mean workload and energy expenditure. We agree that the description of the 10x1 protocol should be improved and have added the following: "The LV-HIT consists of a 10-minute warm up at light to moderate intensity at 60-70% of maximal heart rate (HRmax) followed by ten 1-minute work bouts at the maximal intensity the participants can complete for one minute. In the initial training session, intensity will be set corresponding to 100% of the workload the participant reached at the baseline VO2max test. Participants will be instructed to try reaching 90% of HRmax during the third or fourth work-bout, based on previous findings from Little et al.37 The work bouts are separated by one minute of passive or low-intensity recovery, trying to reach 60-70% of HRmax." 8. Regarding the outcomes, please in the end of the description of each outcome state if its assessment will be blinded or not when adequate (e.g. ovarian morphology; endothelial function; etc.). Response: We have now stated if the assessments of outcomes will be blinded under each outcome. 9. The assessment of the primary outcome should be better described. It is not clear if the participants will complete the questionnaire every month or only at the specific time points (pre, post-16 weeks and 12 months). If the participants complete the questionnaires at the specific time points, it is not clear if they will inform about their menstrual frequency retrospectively or only at this specific month. Also, describe the questionnaire that the participants will answer. Is it a valid questionnaire? Is it specific for PCOS women? Please, clarify. Response: Participants report menstruation each month, and retrospectively at each time point. We have now added some information to the assessment of primary outcome: "They will send their menstruation diary to the study personnel after each menstrual cycle, and the study personnel will send out reminders to fill out the diary. In addition, participants will complete a questionnaire about their menstrual cycle at each assessment point (baseline, 16 weeks, and 12 months) ." Questions about their menstrual cycle are obtained from the The Nord-Trøndelag Health study (HUNT study) (women in fertile age), The Metformin in pregnant PCOS women study (PregMet study) (women with PCOS), and The Norwegian mother and child cohort study (MoBa study). All validated.
In the cardiorespiratory fitness assessments, please clarify which criteria will be used to define a maximal graded exercise test. In addition, the authors state that the HRmax obtained in the maximal graded exercise test will be used for HIIT prescription. This is not clear for the 10x1 HIIT protocol. Please, describe how the HRmax will be used to prescribe the low-volume HIIT. Or it will be used only for the HIIT intensity monitoring? Response: The cardiorespiratory fitness test will be considered successful with a plateau in VO2max with further increase in workload, and a respiratory exchange ratio (RER) ≥1.05. VO2max will be calculated as the average of the three highest consecutive 10-sec measurements. HR will be used to monitor both protocols, and we have tried to describe the 10x1 min protocol better regarding exercise intensity.
10. Regarding the monitoring of physical activity as a possible confounding variable, please describe which questionnaire will be used. Response: Questions about physical activity are obtained from the The Nord-Trøndelag Health study (HUNT study). Participants will also wear activity monitors after each time-point. 11. Regarding the body composition assessment two different methods will be used in the centers, which are bioelectrical impedance and DXA. These methods are very different and have different magnitudes of technical error of measurement and reliability. How the authors will analyzed the data related to body composition (i.e. which variables; separate data per center or all together; etc.)? Also, please states the implications of using two very different methods to assess body composition in the same study. Response: We agree that there are implications with using two different methods to assess body composition. To avoid the two methods implicating our body composition data 1) we will make sure that all participants have their pre and post body composition assessments done with the same method (e.g. either bioelectrical impedance or DXA) and 2) we will analyze the data related to body composition as delta changes. We have added the following section: "The Inbody 720 and DXA are both reliable methods to measure fat-free mass (FFM), body fat percentage (BF%) and fat mass (FM) but it has been shown that the InBody 720 overestimates FFM and underestimates BF% and FM compared to DXA .57 For each individual participant, the same measurement method will be used (InBody 720 in Norway and DXA in Australia) and our purpose is to evaluate changes in body composition (i.e. delta changes)." 12. Regarding the enjoyment outcome, it is not clear how a subgroup of participants and how many will be chosen to answer the PACES questionnaire. It will be a random process? Please, describe this procedure. The enjoyment will be assessed at the supervised or unsupervised sessions or both? Please, clarify. If only in the supervised sessions it would be a considerable source of bias for this outcome given that at supervised setting the participants can have a verbal encouragement, support and motivation from the research staff. Also, they can have a social support from other participants. Together, these aspects can influence perceived enjoyment of an exercise training session. This should be better described especially because recent literature has showed conflicting findings regarding affective response (i.e. pleasure/displeasure) during and enjoyment after HIIT sessions in different populations. Response: The enjoyment assessments will be performed on the last 40 participants included to the trial. Enjoyment will only be assessed at the supervised session, more specifically one of the weekly sessions for all these participants. This is now specified in the manuscript. We agree that assessing enjoyment only at the supervised sessions can imply some bias regarding the true feelings of enjoyment of the exercise. We have therefore added the following to the limitations paragraph: "Assessing enjoyment of exercise only at the supervised sessions could imply a bias. On the supervised sessions the participants will receive motivational support from the researchers and potentially also social support from other participants that can affect their ratings of enjoyment. The enjoyment ratings are, however, implemented to compare the perceived enjoyment of the two HIT protocols." 13. Regarding the sample size calculation, the expected change from 4.5 for 7.5 menstrual bleedings per year in the exercise group is based on a previous study? Please, justify. Also, do the authors expect any difference from the HIIT groups? If yes, any statistical approach was used to allow comparisons between these groups with adequate power?
Response: There exists few long-term RCTs on PCOS, menstrual frequency and exercise, and results are reported in different ways. Therefore, our sample size calculation is based on reported results from several studies that have found positive effects of exercise training on menstrual frequency (Vigorito et al 2007 , Palomba et al 2007 Thomson et al 2008 Nybacka 2011 . For example, one study by Thomson et al (2008) found improved menstrual frequency during a 20 weeks intervention period in the diet only group (2,25 menses), diet and aerobic exercise group (3,3 menses) and diet and combined aerobic and resistance exercise group (3,0 menses). Based on these results, we estimated that the exercise groups would have had between 7,8-8,6 menses/year. We therefore expect to find an increase in the number of menstrual cycles that are equal to what we estimated from the study by Thomson and colleges.
The comparison between the two different HIT protocols will be exploratory. Differences in health outcomes, as well as adherence rates to the HIT protocols will be of great interest in regards to finding ways to implement exercise in a real-life setting.
14.
Blinding. It is a nice approach to run all the statistical analyses blinded for group allocation. However, the primary outcome assessment is not blinded. Why menstrual frequency assessment was not blinded? Response: All outcomes will be blinded in the statistical analyses. Menstrual frequency questionnaires will be blinded, however, the menstruation diaries from baseline and follow-up will be sent to the investigators by e-mail, and will therefore not be blinded. Discussion 1. The authors do not discuss the scientific and clinical implications of the comparisons between the effects of both HIIT protocols. Please, clarify. Response: We have now added the following paragraph to the Discussion: "This is of great interest, as we need to find exercise and lifestyle programs that are feasible over time and that can be easily implemented in everyday life. Exercise programs that are efficient in a research setting, are not necessarily effective in a real-life setting. Thus, there is a great need of studies with a longer intervention and follow-up period." 2. The authors do not discuss the limitations of the trial design and outcomes analyzed, especially the primary outcome. Please, clarify. Response: We have added the following limitation paragraph to our manuscript: "Our trial has some limitations. The use of menstrual frequency as a proxy for ovulation/reproductive function is one of these. Due to practical reasons, we are not able to undertake ovulation monitoring. The Inbody 720 and DXA are both reliable methods to measure Fat-free mass (FFM), Body fat percentage (BF%) and Fat mass (FM) but it has been shown that the InBody 720 overestimates FFM and underestimates BF% and FM compared to DXA (McLester et al., 2018) . For each individual participant, the same measurement method will be used (InBody 720 in Norway and DXA in Australia). Our purpose is to
